HALO logo

Halozyme Therapeutics (HALO) EV/EBITDA

EV/EBITDA:

11.12-0.06(-0.54%)
June 20, 2025

Summary

  • As of today (June 22, 2025), HALO EV/EBITDA is 11.12, with a fall of -0.06 (-0.54%) during the most recent trading session on June 20, 2025.
  • Over the past year, HALO EV/EBITDA has dropped by -4.79 (-30.11%).
  • HALO EV/EBITDA is now -99.65% below its all-time high of 3163.18.

Performance

HALO EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherHALOvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

HALO EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday-0.5%-0.5%-0.6%
1 m1 month-1.1%-1.0%-1.2%
3 m3 months-15.6%-15.5%-17.9%
6 m6 months-11.5%+7.5%+12.5%
ytdytd--+10.5%
1 y1 year-30.1%-0.5%+3.8%
5 y5 years+119.3%+117.5%+116.1%

HALO EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month11.69-4.9%11.12at low
3 m3-month14.16-21.5%10.27+8.3%
6 m6-month14.16-21.5%10.27+8.3%
1 y1-year18.37-39.5%10.27+8.3%
3 y3-year32.43-65.7%10.27+8.3%
5 y5-year140.85-92.1%-218.09+105.1%
alltimeall time3163.18-99.7%-218.09+105.1%

HALO EV/EBITDA History

DateValue
2025
11.12(-17.1%)
2023
13.42(-52.7%)
2022
28.36(+16.9%)
2021
24.27(-38.3%)
2020
39.33(-182.2%)
2019
-47.85(+30.0%)
2018
-36.82(-207.9%)
2017
34.13(-289.8%)
2016
-17.98(-79.5%)
2015
-87.86(+346.2%)
DateValue
2014
-19.69(-10.6%)
2013
-22.02(+68.0%)
2012
-13.11(-73.8%)
2011
-50.13(+270.8%)
2010
-13.52(+63.7%)
2009
-8.26(+4.0%)
2008
-7.94(-52.0%)
2007
-16.55(-50.1%)
2006
-33.19(+389.5%)
2005
-6.78(-34.1%)
2004
-10.29

FAQ

  • What is Halozyme Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Halozyme Therapeutics?
  • What is Halozyme Therapeutics EV/EBITDA year-on-year change?

What is Halozyme Therapeutics EV/EBITDA?

The current EV/EBITDA of HALO is 11.12

What is the all time high EV/EBITDA for Halozyme Therapeutics?

Halozyme Therapeutics all-time high EV/EBITDA is 3163.18

What is Halozyme Therapeutics EV/EBITDA year-on-year change?

Over the past year, HALO EV/EBITDA has changed by -4.79 (-30.11%)
On this page